Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Newsfile Corp Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Wise Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - WSE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Wise Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - WSE

New York, New York--(Newsfile Corp. - August 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Wise Group plc (NASDAQ: WSE) between May 11, 2026 and July 23, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

İlgili Semboller 1
WPLCF WPLCF
Kaynak: Newsfile Corp
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Proactive Investors Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
AppLovin reports second quarter revenue below Wall Street estimates

AppLovin reports second quarter revenue below Wall Street estimates

AppLovin Corp (NASDAQ:APP) shares plunged more than 24% in after-hours trading on Wednesday after the mobile advertising and marketing platform reported second quarter revenue below Wall Street expectations, despite posting strong year-over-year growth and earnings in line with estimates. AppLovin reported revenue of $1.924 billion for the quarter ended June 30, up 53% from $1.259 billion a year earlier but below the $1.94 billion consensus estimate.

İlgili Semboller 1
APP APP
Kaynak: Proactive Investors
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up

HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up

HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress and reaffirmed 2026 guidance add momentum.

İlgili Semboller 1
HRMY HRMY
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated

Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated

Harmony Biosciences Holdings, Inc. has now elevated BP-205, its orexin-2 receptor agonist, to lead the pipeline. HRMY management has become even more specific about business development—exactly the kind of thing I thought was missing earlier. My updated valuation suggests most of the improvement is now reflected in the stock. I am, therefore, upgrading HRMY from Sell to Hold.

İlgili Semboller 1
HRMY HRMY
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Forbes Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
SpaceX Shares Plunge 13% As Elon Musk's Fortune Sheds $80 Billion—Here's What Analysts Are Saying

SpaceX Shares Plunge 13% As Elon Musk's Fortune Sheds $80 Billion—Here's What Analysts Are Saying

Some brokerages appeared optimistic about SpaceX's quarterly earnings: JPMorgan analysts, who lifted their price target for shares to $240 from $225, wrote SpaceX is benefiting from “extreme vertical integration” while noting its “pace of change in AI is incredibly fast,” and that a step-up in AI infrastructure and higher monetization could push SpaceX's AI revenue to $100 billion in 2027. Wells Fargo analysts cut their price target for SpaceX shares to $215 from $230 amid broader caution about its AI spending, noting that SpaceX was “off to an ambitious start” and that revenue projections for 2027 and 2028 were higher than expected, but so were capital expenditure estimates.

İlgili Semboller 1
SPCX SPCX
Kaynak: Forbes
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Schwab Network Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Why CFRA Holds a Sell Rating on SPCX

Why CFRA Holds a Sell Rating on SPCX

CFRA's Keith Snyder says "there was a lot to like" in SpaceX (SPCX) earnings, but he points to a red flag in the company's capex spending levels. He also likes the "firm" computing power contracts SpaceX holds but he wants to hear if the company can grow "on its own without renting out excess capacity.

İlgili Semboller 1
SPCX SPCX
Kaynak: Schwab Network
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: GlobeNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

SUNNYVALE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the second quarter of 2026 by conference call on Wednesday, August 12, 2026 at 4:30 PM EDT. Following management's formal remarks, there will be a question-and-answer session.

İlgili Semboller 1
BCDA BCDA
Kaynak: GlobeNewsWire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap